Beispiel: Heart Attack

Klinische Studien gesponsert von Respivert Ltd

Insgesamt 11 ergebnisse

NCT02517359

Beendet

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153

Bedingungen: Asthma; Healthy Volunteers
NCT02490358

Abgeschlossen

Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers

Bedingungen: COPD; Asthma
NCT02140346

Abgeschlossen

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD

Bedingungen: Chronic Obstructive Pulmonary Disease
NCT02140320

Abgeschlossen

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days

Bedingungen: Asthma; Healthy Volunteers
NCT01970618

Abgeschlossen

Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients

Bedingungen: Chronic Obstructive Pulmonary Disease (COPD); Healthy Volunteers
NCT01813084

Abgeschlossen

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729

Bedingungen: Asthma; Healthy Volunteers
NCT01676467

Abgeschlossen

Sample Collection in Smoking Asthma

Bedingungen: Asthma
NCT01661244

Abgeschlossen

A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

Bedingungen: COPD; Healthy Volunteers
NCT01475292

Abgeschlossen

A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Bedingungen: Chronic Obstructive Pulmonary Disease
NCT01230645

Abgeschlossen

RV568 - Viral Challenge With RSV

Bedingungen: Respiratory Syncytial Virus Infections
NCT01230619

Abgeschlossen

Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis

Bedingungen: Seasonal Allergic Rhinitis